Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Kristine S. Wong"'
Autor:
Kristine S. Wong, Justine A. Barletta
Publikováno v:
Surgical Pathology Clinics. 16:27-44
Autor:
Kristine S. Wong, Justine A. Barletta
Publikováno v:
Cancer Cytopathology. 130:658-662
The new World Health Organization classification of endocrine tumors will include many updates on thyroid pathology. This summary highlights the changes that are most relevant for cytopathologists.
Autor:
Jessica F. Williams, Melissa Zhao, Fedaa Najdawi, Sara Ahmadi, Jason L. Hornick, Kristine S. Wong, Justine A. Barletta
Publikováno v:
Endocrine Pathology. 33:371-377
Autor:
Hansen Lam, Carla Saoud, Qiuying Shi, Kristine S. Wong, Edmund S. Cibas, Lisa M. Rooper, Zubair Baloch, Syed Z. Ali
Publikováno v:
Journal of the American Society of Cytopathology.
Publikováno v:
Histopathology. 79:491-498
BACKGROUND AND AIMS Columnar cell variant (CCV) is a rare papillary thyroid carcinoma subtype. The majority of CCV occur in older patients and are large, invasive tumours that pursue an aggressive clinical course. Rare well-circumscribed CCV occur in
Publikováno v:
Diagnostic Histopathology. 27:231-239
Hurthle cells (HC) are characterized by abundant granular eosinophilic cytoplasm containing accumulated dysfunctional mitochondria and large nuclei with prominent nucleoli. Based on the distinct clinicopathologic and molecular characteristics of Hurt
Autor:
Jessica F, Williams, Melissa, Zhao, Fedaa, Najdawi, Sara, Ahmadi, Jason L, Hornick, Kristine S, Wong, Justine A, Barletta
Publikováno v:
Endocrine pathology. 33(3)
Grade, based on proliferative activity and tumor necrosis, has recently been shown to be prognostic in medullary thyroid carcinoma (MTC) in multivariate analysis. The aim of this study was to evaluate the interobserver reproducibility of assessed gra
Autor:
Jochen H. Lorch, Christopher A. French, Jonathan D. Schoenfeld, Gerard M. Doherty, Justine A. Barletta, Jeffrey Swanson, Kristina Danga, Matthew A. Nehs, Kristine S. Wong, Raphael Bueno, Alarice C. Lowe, Francis D. Moore, Lindsay E. Kuo, Abby White
Publikováno v:
Clinical Thyroidology. 33:38-47
Publikováno v:
Head Neck Pathol
Acinic cell carcinoma (AciCC) harbors a recurrent t(4;9)(q13;q31) translocation, which leads to upregulation of Nuclear Receptor Subfamily 4 Group A Member 3 (NR4A3). Previous work on tissue microarrays suggests that NR4A3 immunohistochemistry (IHC)
Publikováno v:
Histopathology. 77:314-320
Aims Treatment with a BRAF inhibitor, alone or in combination with a MEK inhibitor, may be considered for BRAF-mutant anaplastic thyroid carcinoma (ATC). The purpose of this study was to characterise the histology of BRAF V600E-mutant ATC. Methods an